In vitro de-differentiation or reprogramming of melanoma cells has been described previously.20,30–32Nras and Braf-mutated melanoma cells were partially reprogrammed to study genetic and molecular changes during the intermediate stages of tumour progression. This evidence concerns the gene BRAF and melanoma.